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Abstract
Introduction: Nonfocal transient neurological attacks (TNAs) are episodes with atypical, nonlocalizing cerebral symp-
toms. We examined the prevalence of nonfocal TNAs, in patients with and without carotid artery occlusion (CAO).
Methods: We included 67 patients with CAO and 62 patients without CAO. In both groups, patients had a history of
transient ischemic attack (TIA) or nondisabling ischemic stroke in the anterior circulation that had occurred >6 months
before inclusion. Patients without CAO did not have ipsilateral or contralateral carotid artery stenosis of 50%. All
patients were interviewed with a standardized questionnaire on the occurrence of nonfocal TNA symptoms during the
preceding six months. We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for the occurrence of 1 and
2 different nonfocal TNAs after adjustments for age, sex, systolic blood pressure and time interval between most
recent TIA or ischemic stroke and administration of the questionnaire.
Results: Forty-three of all patients (33%) had had one or more nonfocal TNAs in the preceding six months.
Nonrotatory dizziness (24%) was reported most often. The prevalence of 1 nonfocal TNAs was not significantly
different between patients with and without CAO (39% vs. 27%; adjusted RR 1.47, 95% CI 0.83–2.61), but the prev-
alence of 2 or more different nonfocal TNAs was higher in patients with CAO (16% vs. 3%; adjusted RR 4.77, 95% CI
1.20–18.98). In patients with CAO who also had a contralateral carotid or vertebral artery steno-occlusion, nonfocal
TNAs occurred more often than in patients without any carotid or vertebral artery steno-occlusion (46% vs. 27%;
adjusted RR 2.22, 95% CI 1.08–4.60 for 1 and 21% vs. 3%; adjusted RR 8.27, 95% CI 1.83–37.32 for 2 nonfo-
cal TNAs).
Conclusions: Patients with CAO more often experienced multiple nonfocal TNAs than patients without CAO.
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Introduction
Nonfocal transient neurological attacks (TNAs) are
defined as attacks with atypical, nonlocalizing cerebral
symptoms such as unsteadiness, confusion or bilateral
weakness.1,2 Patients with nonfocal TNAs are at higher
risk of cardiac events, stroke and dementia than
patients without nonfocal TNAs.2,3 Even though they
are by no means benign, the underlying pathophysiol-
ogy of nonfocal TNAs is still poorly understood. Both
cerebral ischemia and cerebral hypoperfusion have
been suggested to play a role.1,3–5 Factors that might
contribute to cerebral hypoperfusion are severe
obstruction of cerebropetal arteries and impaired
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cerebral autoregulation.6 We therefore hypothesized
that in patients with carotid artery occlusion (CAO),
nonfocal TNAs are more prevalent than in patients
without CAO.
Methods
Study population and design
We selected patients from two prospective observation-
al cohort studies.7,8
Patients with CAO were selected from the Heart-
Brain Connection (HBC) study, which is a multicenter
cohort study in the Netherlands that focusses on the
relation between cardiovascular and hemodynamic
measures and cognitive impairment.7 From all consec-
utive patients with CAO who participated in the HBC
study from November 2014 to March 2017 (data
release 1 October 2017), we included all patients with
CAO who had experienced an ipsilateral transient
ischemic attack (TIA) or nondisabling ischemic stroke
more than six months before inclusion. CAO was
defined as a complete occlusion of the internal carotid
artery and was measured either with ultrasound, mag-
netic resonance angiography or computed tomography
angiography.
Patients without CAO were selected from the
Second Manifestations of ARTerial disease (SMART)
study from November 2015 until September 2017. The
SMART study is a cohort study executed by a single
academic hospital in the Netherlands, including
patients with vascular risk factors or clinical manifest
vascular disease.8 Eligible patients had a history of TIA
or nondisabling ischemic stroke of the anterior circula-
tion that had occurred more than six months before
inclusion and did not have a stenosis of the ipsilateral
or contralateral carotid artery of 50% on ultrasound.
Imaging of the internal carotid arteries was performed
<1 year before inclusion into our study.
In both groups, patients were independent in activ-
ities of daily living (modified Rankin Scale of 0–3).
The HBC study and SMART study were approved
by the Ethics Committee of the Leiden UMC and
UMC Utrecht, respectively.7,8 All patients provided
written informed consent.
Study parameters
All patients were interviewed by a trained physician or
research nurse with a standardized questionnaire on the
occurrence of eight nonfocal symptoms in the preced-
ing six months (Table 1). Nonfocal TNAs were defined
as attacks of one or more nonfocal signs or symptoms
with an acute onset, a minimum duration of 30 s and a
maximum of 24 h. The classification of nonfocal
symptoms was adapted from the Rotterdam Study.1,2
Symptoms that were compatible with a different diag-
nosis, such as migraine or epilepsy, were excluded from
the analysis. The researcher who completed the inter-
view was aware of the presence or absence of CAO in
each patient.
In addition, we recorded demographic and clinical
characteristics, including the presence of vascular risk
factors, use of antihypertensive, lipid lowering, antipla-
telet or anticoagulant medication, blood pressure, side
of symptomatic CAO and presence of other extracra-
nial arterial stenosis.
Statistical analysis
We calculated the prevalence of nonfocal TNAs in
both patient groups. We assessed the association
between CAO and the occurrence of nonfocal TNAs
with Poisson regression analysis with robust standard
errors.9 We calculated crude and adjusted risk ratios
(RR) with corresponding 95% confidence intervals
(CIs) for the occurrence of 1 and 2 different non-
focal TNAs. Adjustments were made for age, sex, sys-
tolic blood pressure and time interval between most
recent TIA or ischemic stroke and questionnaire, as
these factors were considered a priori to be potential
confounders of the association between CAO and the
occurrence of nonfocal TNAs. Subgroup analyses were
performed in patients without steno-occlusion of the
vertebral arteries, and in patients with CAO who also
had had a contralateral carotid or vertebral artery
steno-occlusion versus patients without any carotid or
vertebral artery steno-occlusion.
Results
We included 67 patients with CAO and 62 patients
without CAO. Mean age was 66 (9) years. Patients
with CAO were more often male, had more vascular
Table 1. Occurrence of different types of nonfocal TNA
symptoms in the past six months.







Blurred vision 6 (9%) 2 (3%)
Bilateral leg weakness 4 (6%) 1 (2%)
Unsteadiness 6 (9%) 0 (0%)
Nonrotatory dizziness 18 (27%) 13 (21%)
Paresthesias 0 (0%) 4 (7%)
Unconsciousness 4 (6%) 0 (0%)
Confusion 2 (3%) 0 (0%)
Amnesia 1 (2%) 0 (0%)
TNA: transient neurological attack.
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risk factors and had higher systolic blood pressure than
those without CAO (Table 2). Seven (11%) of patients
with CAO had a contralateral asymptomatic carotid
artery stenosis of 50% and six (9%) had a contralat-
eral CAO. Fifteen (23%) patients with CAO also had
>50% stenosis of a vertebral artery.
Table 1 summarizes the different nonfocal symp-
toms. Forty-three of all patients (33%) had had one
or more nonfocal TNAs in the preceding six months
(Supplementary Figure 1). The prevalence of at least
one nonfocal TNA was not significantly different
between patients with and without CAO (39% vs.
27%; adjusted RR 1.47, 95% CI 0.83–2.61; Table 3).
However, the prevalence of two or more different non-
focal TNAs was significantly higher in patients
with CAO (16% vs. 3%; adjusted RR 4.77, 95% CI
1.20–18.98; Table 3).
Exclusion of patients with vertebral artery steno-
occlusion (n¼ 21, 16%) yielded comparable results
(Table 3). In a post-hoc analysis, nonfocal TNAs
occurred more often in patients with both CAO and
a contralateral carotid or vertebral artery steno-
occlusion (n¼ 28) than in patients without any carotid
or vertebral artery steno-occlusion (n¼ 59) (46% vs.
27%; adjusted RR 2.22, 95% CI 1.08–4.60 for 1
and 21% vs. 3%; adjusted RR 8.27, 95% CI 1.83–
37.32 for 2 nonfocal TNAs) (Table 4).
Discussion
We found that one-third of patients with a distant his-
tory of TIA or nondisabling ischemic stroke of the
anterior circulation experienced nonfocal TNAs in
the preceding six months. The prevalence of multiple
nonfocal TNAs was higher in patients with CAO than
in those patients without CAO. Also, the prevalence of
one or more nonfocal TNAs was higher in patients
with CAO who also had a contralateral carotid or ver-
tebral artery steno-occlusion than in patients without
any cerebropetal steno-occlusion.
Studies on the prevalence of nonfocal TNAs are lim-
ited. In a previous population-based study, 2% of
Table 2. Patient characteristics.
Carotid occlusion (n¼ 67) No carotid occlusion (n¼ 62)
Age in years, mean (SD) 65.3 (7.9) 65.8 (9.8)
Male sex, n (%) 51 (76%) 37 (60%)
Hypertension, n (%) 52 (78%) 39 (63%)
Hyperlipidemia, n (%) 61 (91%) 24 (39%)
Current smoking, n (%) 17 (25%) 11 (18%)a
Diabetes mellitus, n (%) 21 (31%) 11 (18%)
History of, n (%)
Myocardial infarction 9 (13%) 5 (8%)
Peripheral arterial disease 21 (31%) 2 (3%)
TIA (including amaurosis fugax) 50 (75%) 22 (36%)
Ischemic stroke 38 (57%) 42 (68%)
Medication use, n (%)
Antiplatelet 56 (84%) 48 (77%)
Anticoagulant 6 (9%) 10 (16%)
Antihypertensive 47 (70%) 32 (52%)
Lipid lowering 59 (88%) 50 (81%)
Systolic blood pressure in mmHg, mean (SD) 152.1 (21.1) 136.3 (15.0)b
Diastolic blood pressure in mmHg, mean (SD) 82.7 (12.1) 80.3 (10.8)b
Stenosis of extracranial cerebral arteries, n (%)
Contralateral ICA stenosis 50% or occlusion 13 (20%)c NA
VA stenosis 50% or occlusion 15 (23%)c 3 (5%)
Side of symptomatic carotid occlusion, n (%)
Right 31 (46%) NA
Left 30 (45%) NA
Both 6 (9%) NA
Interval between most recent TIA or ischemic stroke
and questionnaire in years, median (IQR)
3.7 (1.9–8.9) 1.8 (1.0–10.5)
SD: standard deviation; TIA: transient ischemic attack; ICA: internal carotid artery; VA: vertebral artery; IQR: interquartile range; NA: not applicable.
aMissing in n¼ 1 (2%).
bBlood pressure was measured before administration of questionnaire (<1 year earlier).
cMissing in n¼ 3 (5%).
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patients (>55 years) experienced a nonfocal TNA in
the preceding three years.1 In another hospital-based
study, nonfocal symptoms occurred more frequently
in patients with a recent TIA or nondisabling ischemic
stroke; 20% of patients without carotid or vertebral
artery stenosis, 36% of patients with carotid artery ste-
nosis and 54% of patients with vertebral artery stenosis
experienced nonfocal TNAs in the six months preced-
ing the cerebral ischemic event.10 Our findings are com-
patible with these results.
Although we can only hypothesize, the higher prev-
alence of multiple nonfocal TNAs in patients with
versus without CAO might be caused by cerebral hypo-
perfusion due to CAO. Our finding that these differ-
ences in prevalence were even more profound in
patients with both CAO and a contralateral carotid
or vertebral artery steno-occlusion supports a hemody-
namic etiology.
Our study has some limitations. To start, although
we tried to make the group without CAO comparable
to the CAO group with regards to vascular risk factors
and risk of ischemic stroke by including only patients
with a distant history of TIA or nondisabling ischemic
stroke as our control population, vascular risk factors
and previous vascular diseases were more often present
in the CAO group. Although we cannot rule out resid-
ual confounding, we have adjusted our analysis for
those variables that we considered potential confound-
ers of the association between presence of CAO and
occurrence of nonfocal TNAs. Second, the time inter-
val between the most recent cerebral ischemic event and
administration of the questionnaire was longer in
patients with CAO than in patients without CAO.
Patients with a more recent event may have been
more aware of what symptoms they experienced in
the previous six months which may have underesti-
mated the prevalence of nonfocal TNAs in patients
with CAO. However, this would only have enhanced
the difference between patients with and without CAO
and adjustment for this time interval did not have a
large influence on the effect estimates. Third, the diag-
nosis of a nonfocal TNA can be difficult and the ques-
tionnaire was administered by several different
unblinded interviewers which carries the risk of mis-
classification. However, we used a standardized ques-
tionnaire and systematically asked for nonfocal TNAs.
Last, we had no detailed information regarding diag-
nostic examinations in patients with nonfocal TNAs
Table 4. Occurrence of nonfocal TNAs in the past six months in patients with CAO and VA or contralateral carotid steno-occlusion











Occurrence of 1 different TNA symptoms, n (%) 13 (46%) 16 (27%) 1.71 (0.96–3.05) 2.22 (1.08–4.60)c
Occurrence of 2 different TNA symptoms, n (%) 6 (21%) 2 (3%) 6.32 (1.36–29.36) 8.27 (1.83–37.32)d
TNA: transient neurological attack; CAO: carotid artery occlusion; VA: vertebral artery; RR: risk ratio; CI: confidence interval.
aPatients with both CAO and a contralateral carotid artery steno-occlusion or vertebral artery steno-occlusion.
bPatients without steno-occlusion of the carotid and vertebral arteries.
cAdjusted for age, sex, systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.
dAdjusted for systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.
Table 3. Occurrence of nonfocal TNAs in the past six months in patients with and without CAO, and in the subgroup of patients












Occurrence of 1 different TNA symptoms, n (%) 26 (39%) 17 (27%) 1.42 (0.86–2.34) 1.47 (0.83–2.61)a












Occurrence of 1 different TNA symptoms, n (%) 16 (33%) 16 (27%) 1.20 (0.67–2.15) 1.08 (0.56–2.10)a
Occurrence of 2 different TNA symptoms, n (%) 8 (16%) 2 (3%) 4.82 (1.07–21.64) 4.02 (0.99–16.35)b
TNA: transient neurological attack; CAO: carotid artery occlusion; RR: risk ratio; CI: confidence interval; VA: vertebral artery.
aAdjusted for age, sex, systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.
bAdjusted for systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.
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and as such could not be completely sure that other
diagnoses were ruled out.
In conclusion, our study indicates that nonfocal
TNAs are highly common in patients with a distant
TIA or nondisabling stroke. Patients with CAO expe-
rience multiple nonfocal TNAs more often than
patients without CAO. Since nonfocal TNAs are
highly prevalent and it is unknown whether they
should be a reason to adapt clinical management,
future research is needed to understand underlying
mechanisms and prognosis.
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